Journal article
The challenging approach to the management of male partners of HPV-positive women
Human vaccines & immunotherapeutics, Vol.21(1), 2515753
12/2025
DOI: 10.1080/21645515.2025.2515753
PMCID: PMC12169029
PMID: 40511955
Abstract
Human papillomavirus (HPV) is the most prevalent sexually transmitted infection globally, with significant implications for both individual and public health. While management protocols for HPV-positive women are well-defined, limited and controversial guidance exists for their male partners, creating challenges in clinical practice. This commentary aims to turn the attention to the clinical, psychological, and preventive considerations for male partners of HPV-positive women, emphasizing the need for evidence-based recommendations. It presents the psychological impact of HPV on couples, and the role of preventive measures such as vaccination. Key focus areas included partner notification, HPV testing in men, and risk-reduction strategies. HPV infections in male partners can lead to conditions ranging from genital warts to HPV-associated cancers. Despite the absence of routine HPV testing for men, targeted interventions, including vaccination, have demonstrated effectiveness in reducing HPV transmission and associated cancer risks. The management of male partners of HPV-positive women remains an underexplored and controversial domain, necessitating the development of comprehensive, evidence-based guidelines. Integrating vaccination, partner counseling, and targeted clinical approaches could address existing gaps and ensure equitable care for both partners.
Details
- Title: Subtitle
- The challenging approach to the management of male partners of HPV-positive women
- Creators
- Jacob Bornstein - Bar-Ilan UniversityPedro Vieira-Baptista - Universidade do PortoColleen Stockdale - University of IowaMario Preti - Department of Surgical Sciences, University of Torino, Torino, ItalyElmar Joura - Medical University of ViennaEduardo Schejter - Woman Health Center and Lower genital tract unit, Maccabi HMO, Tel-Aviv, Israel
- Resource Type
- Journal article
- Publication Details
- Human vaccines & immunotherapeutics, Vol.21(1), 2515753
- DOI
- 10.1080/21645515.2025.2515753
- PMID
- 40511955
- PMCID
- PMC12169029
- NLM abbreviation
- Hum Vaccin Immunother
- ISSN
- 2164-554X
- eISSN
- 2164-554X
- Publisher
- TAYLOR & FRANCIS INC
- Language
- English
- Date published
- 12/2025
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9984829025202771
Metrics
10 Record Views